Stockscreener 앱 받기
1.24
0.80%
-0.01
시간 외 거래:
1.25
0.01
+0.81%
전일 마감가:
$1.25
열려 있는:
$1.25
하루 거래량:
900.96K
Relative Volume:
0.58
시가총액:
$132.94M
수익:
$11.16M
순이익/손실:
$-148.13M
주가수익비율:
-0.7806
EPS:
-1.5885
순현금흐름:
$-112.35M
1주 성능:
-4.62%
1개월 성능:
-29.55%
6개월 성능:
-34.04%
1년 성능:
-35.75%
1일 변동 폭
$1.22
$1.27
1주일 범위
$1.22
$1.36
52주 변동 폭
$1.22
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
Compare CRBU vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.24 | 132.94M | 11.16M | -148.13M | -112.35M | -1.5885 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 개시 | Evercore ISI | Outperform |
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences Inc (CRBU) Stock Price Target & Forecast - tradingkey.com
Caribou Biosciences (CRBU) Loses 19.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Caribou (CRBU) Today: Gains 3.11% to Reach $1.66 at the Close; Key Range: $1.58 and $1.74 Define the Nearby Reference Levels under the Current SnapshotVOLD Alert - vinanet.vn
Caribou Biosciences Inc (CRBU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Caribou (CRBU) Quarterly Figures: EPS Comes in Above Forecast in the Latest Reading; Share Move - vinanet.vn
Caribou Biosciences (CRBU) Slips 1.86% to $1.58 as Gene-Editing Stock Tests Key Support LevelPut Wall - dars.gov.et
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Caribou Biosciences (NASDAQ:CRBU) Price Target Cut to $5.00 by Analysts at Bank of America - MarketBeat
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Caribou Biosciences, Inc. Stock 12‑Month Price Target Cut to $11.86, Implies 636% Upside - TradingView
Caribou Biosciences earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
BofA Adjusts Price Target on Caribou Biosciences to $5 From $6 - Yahoo Finance
Caribou Biosciences (NASDAQ:CRBU) Releases Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Caribou Biosciences Q2 EPS beats estimate, sales miss - scanx.trade
Form 8K Caribou Biosciences Inc For: 13 August By Investing.com - Investing.com Australia
Caribou Biosciences, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
CARIBOU BIOSCIENCES ($CRBU) Releases Q2 2026 Earnings - Quiver Quantitative
Caribou Biosciences reports Q2 2026 results: $1.5M licensing revenue, $24.3M GAAP net loss - TradingView
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Caribou's Single-Dose CAR-T Shows 92% Response in 12 Myeloma Patients - Stock Titan
Caribou Biosciences (CRBU) Holds Near $1.70 as Gene-Editing Pipeline Remains in FocusValue Area High - vinanet.vn
CRBU Q1 2026 Earnings: Narrower-Than-Expected Loss Reflects Cost DisciplineEarnings Cycle Report - careplusvn.com
Caribou Biosciences, Inc. expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Number of shareholders of Caribou Biosciences, Inc. – NASDAQ:CRBU - TradingView
Caribou Biosciences, Inc. $CRBU Stock Holdings Raised by Renaissance Technologies LLC - MarketBeat
Spotlight On Promising Penny Stocks For August 2026 - Sahm
Caribou Biosciences (CRBU) to Announce Earnings on Wednesday - MarketBeat
CRBU Q2'26 Earnings: revenue estimate is 2.28M USD - TradingView
Caribou (CRBU) Stock Analysis: Climbs +4.67%, Eyes on $1.65 2026-08-04Charm Flow - vinanet.vn
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - TMX Newsfile
Caribou Biosciences (CRBU) Pulls Back to $1.46 as Clinical-Stage Biotech Faces Selling PressurePut Call Ratio - careplusvn.com
Caribou Biosciences Inc expected to post a loss of 32 cents a shareEarnings Preview - tradingview.com
Caribou Biosciences (CRBU) Holds Steady at $1.47 as Biotech Sector Watches Key LevelsContinuation Pattern Picks - careplusvn.com
BMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that. - pharmavoice.com
Caribou Biosciences (CRBU) Falls 6% as Biotech Sentiment WeakensSentiment Shift - dars.gov.et
CRBU|Caribou Biosciences Inc|Price:1.650|Chg%:+0.010 - TradingKey
CRBU|Caribou Biosciences Inc|Price:1.585|Chg%:+0.015 - TradingKey
Caribou Biosciences Inc (CRBU) Valuation: PE, PB & Fair Value Analysis - tradingkey.com
Caribou Biosciences Inc (CRBU) Cash Flow - TradingKey
BlackRock (NYSE: BLK) reports 7.2% beneficial stake in Caribou Biosciences (CRBU) - Stock Titan
Caribou Biosciences Inc (CRBU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Caribou Biosciences Inc (CRBU) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Caribou Biosciences Inc (CRBU) Balance Sheet - tradingkey.com
Enterprise value to EBITDA forward of Caribou Biosciences, Inc. – NASDAQ:CRBU - TradingView
Caribou Biosciences Inc (CRBU) Income Statement - TradingKey
Caribou Biosciences Inc (CRBU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Caribou Biosciences, Inc. Revenue Breakdown – NASDAQ:CRBU - tradingview.com
CRBU|Caribou Biosciences Inc|Price:1.230|Chg%:-0.020 - tradingkey.com
Caribou Biosciences Inc (CRBU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CRBU|Caribou Biosciences Inc|Price:1.570|Chg%:-0.060 - TradingKey
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):